EUVIMEDEUVIMED entdecken
Crossref

Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients

Marina Pieri, Matteo A Bonizzoni, Alessandro Belletti, Maria G Calabrò, Evgeny Fominskiy, Pasquale Nardelli, Alessandro Ortalda, Anna M Scandroglio

Blood Purification · 2023

DOI: 10.1159/000530872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Purification, 2023. Verfasst von Marina Pieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Shock, Cardiogenic, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Critically ill patients with inflammatory dysregulation and organ disfunction may benefit from blood purification, although the use of this technique has not been described in large case series. We evaluated clinical outcomes and survival in high-risk intensive care unit (ICU) patients who underwent extracorporeal blood purification.

Methods

359 consecutive ICU patients treated with CytoSorb were included.

Results

Main admission diagnoses were 120 (34%) refractory cardiac arrest under mechanical chest compression; 101 (28%) profound cardiogenic shock; 81 (23%) post-cardiotomy cardiogenic shock; and 37 (10%) respiratory failure. Fifteen patients (4%) were positive for SARS-CoV-2 infection. We observed 49% 30-day mortality, 57% ICU mortality, and 62% hospital mortality, all lower than the 71% mortality predicted by SAPS II and 68% predicted by SOFA score. Parameters of shock and organ failure, above all vasoactive inotropic score, reduced during CytoSorb treatment. Multivariable analysis identified SAPS II, lactate dehydrogenase, ICU stay duration, vasoactive inotropic score, lactates, intra-aortic counterpulsation on top of VA-ECMO, and total bilirubin as predictors of mortality. No CytoSorb-related complications occurred.

Conclusion

CytoSorb treatment was effective in reducing laboratory parameters of shock and vasoactive inotropic score with possible survival implications in a large population of critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicCOVID-19HumansCritical IllnessHospital MortalityCritical CareRetrospective Studies

Stichwörter der Autor:innen

Artificial organCytokinesExtracorporeal membrane oxygenationHemoperfusionInflammationInflammatory mediatorsMechanical circulatory supportShock

Autor:innen und Institutionen

  • Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Zitieren

APA

Pieri, M., Bonizzoni, M. A., Belletti, A., Calabrò, M. G., Fominskiy, E., Nardelli, P., Ortalda, A., & Scandroglio, A. M. (2023). Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients. Blood Purification. https://doi.org/10.1159/000530872

Vancouver

Pieri M, Bonizzoni MA, Belletti A, Calabrò MG, Fominskiy E, Nardelli P, et al. Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients. Blood Purification. 2023. doi:10.1159/000530872

BibTeX
@article{Pieri2023,
  author = {Pieri, Marina and Bonizzoni, Matteo A and Belletti, Alessandro and Calabrò, Maria G and Fominskiy, Evgeny and Nardelli, Pasquale and Ortalda, Alessandro and Scandroglio, Anna M},
  title = {Extracorporeal Blood Purification with CytoSorb in 359 Critically Ill Patients},
  journal = {Blood Purification},
  year = {2023},
  doi = {10.1159/000530872}
}
Kostenlos starten →